Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
When they release the TLD and positive finance information... (fill in the blank)
I agree. I too have noticed the "correlation". That plus some profit taking is what's going on but that fact still remains that there are lots of eyes on ACTC currently And TLD coming soon. Above 10 cents within 2 weeks in my opinion to say the least. ACTC price to the side, the science is still real and everyday that passes stem cell treatment is getting closer to market. ACTC is in the lead because they are the only ones in FDA trials using Embryonic Stem Cells everyone else is using Adult Stem Cells. If you don't know the difference, I suggest everyone do their DD.
Did anyone read this one?? Seems to me that someone is out to put the nails in the coffin before the resurrection of ACTC occurs through the release of TLD.
http://www.the-scientist.com/?articles.view/articleNo/39005/title/Stem-Cell-Trials-in-Peril-/
The Breakthrough prizes award show aired today on SCI. Robert Langer of ACTC was one of the few winners.
http://m.prnewswire.com/news-releases/2014-breakthrough-prizes-awarded-in-fundamental-physics-and-life-sciences-for-a-total-of-21-million-235691341.html
RELEASE THE KRAKEN.
I believe TLD and Or JV information to be released next week... I feel that this type of negative publicity will help keep watchful eyes on the stock through till the next Big PR. All publicity positive or negative is good publicity. "Release the kraken."
Last night I was watching the SCI channel and a commercial came on about a show that would debut on Feb 3rd narrated by Stephen hawking titled stem cell universe... I recognized Robert Lanza's voice on the commercial... Guess I wasn't the only one.
http://investorstemcell.com/forum/advanced-cell-technology/39174.htm
No mention of actc... SMH.
http://m.medicalxpress.com/news/2014-01-stem-cell-common-age-related.html
http://www.vaildaily.com/news/eaglevalley/9675522-113/stem-cell-vail-medical
I know the news has been out but... This article came out when I googled "stem cell therapy" under news. I think that's great exposure.
One person here, another person there... A few more over there... You get the picture.
What your "best TA scholar" calls a warning I call creating a panic... Plain and simple. It is that type of mentality that creates pull backs. You can stare at charts your entire life but the truth is... "No one knows if the stock is going to go up, down, sideways or in circles."
No not "clearly". Just because I haven't posted does not mean I haven't read. Thank you for your warm welcome.
Clearly you are trying to stop the train Fot personal reasons. IMO the stem cell industry is the next "boom" and 99% Of stem cell companies that survive the R&D phases are volcanoes ready to erupt. IMO it doesn't matter whether you got in at 1$ or 3.70$ as long as you get on the train before its too late and it's next stop is somewhere around the price of a big pharma stock IMO.
Mention of ACTC today
Biotechnology company Advanced Cell Technology (ACT), has been recruiting subjects for phase I and II clinical trials in the United States and Europe since July 2011 to test the safety and tolerability of stem-cell-derived RPE cells in patients with dry macular degeneration at the end of 12 months.
Despite the progressive nature of the eye condition, the vision of ACT's first two subjects appears to have made persistent gains in visual acuity, according to ACT's chief scientific officer Dr Robert Lanza.
http://m.scmp.com/lifestyle/health/article/1386760/nobel-laureate-says-stem-cell-research-leading-breakthrough
Everyone needs to calm down and double down IMO.
Dr. Robert Lanza featured on "beyond the wormhole" with Morgan Freeman on SCI. Channel today.
Interesting thought fern, I'm wondering what it is that gives you that assumption?
Anyone know when they will be administering the last cohort?